Vidya G Doddawad, B M Gurupadayya, Vidya Cs, Shivananda S, Karthikeya Patil, R Sumukh Bharadwaj
{"title":"Advancing Biomedical Research on Salivary Antioxidants: Exploring the Significance in Oral Precancer and Cancer.","authors":"Vidya G Doddawad, B M Gurupadayya, Vidya Cs, Shivananda S, Karthikeya Patil, R Sumukh Bharadwaj","doi":"10.46883/2025.25921038","DOIUrl":null,"url":null,"abstract":"<p><p>Under normal physiological circumstances, an equilibrium exists between prooxidants and antioxidants in the body. The body generates free radicals as part of its natural cellular metabolism. However, when there is an unevenness or modification in the levels of antioxidants, it gives rise to a state known as oxidative stress. This phenomenon is implicated in numerous pathological conditions. It can potentially harm cells by causing minor injuries to cell membranes, deactivating proteins, damaging DNA, and triggering tissue damage through cell-signaling molecules. Human saliva is a diagnostic fluid that is rich in antioxidant compounds and plays a primary role in the protective mechanism. These antioxidants neutralize the free radicals, including reactive oxygen species and reactive nitrogen species, that are released due to oxidative stress and prevent cell breakdown, tissue damage, and DNA mutations. Whole human saliva may contain numerous antioxidants that are measurable tools to monitor the oral cavity's oxidative processes and help guide the development of new drugs or treatment plans. This article provides extensive information on salivary antioxidants and their role in common oral lesions like inflammatory, premalignant, malignant, and autoimmune diseases.</p>","PeriodicalId":51147,"journal":{"name":"Oncology-New York","volume":"39 3","pages":"111-117"},"PeriodicalIF":1.8000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology-New York","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.46883/2025.25921038","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Under normal physiological circumstances, an equilibrium exists between prooxidants and antioxidants in the body. The body generates free radicals as part of its natural cellular metabolism. However, when there is an unevenness or modification in the levels of antioxidants, it gives rise to a state known as oxidative stress. This phenomenon is implicated in numerous pathological conditions. It can potentially harm cells by causing minor injuries to cell membranes, deactivating proteins, damaging DNA, and triggering tissue damage through cell-signaling molecules. Human saliva is a diagnostic fluid that is rich in antioxidant compounds and plays a primary role in the protective mechanism. These antioxidants neutralize the free radicals, including reactive oxygen species and reactive nitrogen species, that are released due to oxidative stress and prevent cell breakdown, tissue damage, and DNA mutations. Whole human saliva may contain numerous antioxidants that are measurable tools to monitor the oral cavity's oxidative processes and help guide the development of new drugs or treatment plans. This article provides extensive information on salivary antioxidants and their role in common oral lesions like inflammatory, premalignant, malignant, and autoimmune diseases.
期刊介绍:
Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.